Malondialdehyde: A novel predictive biomarker for post-stroke depression.

•An association between oxidative stress and post-stroke depression is proposed.•Elevated serum levels of malondialdehyde after admission within 24h are independently associated with the development of 1-month post-stroke depression.•No association between serum antioxidant enzymes and depression after stroke is found.